In Pursuit of Optimal Outcomes: A Framework for Quality Standards in Immune Effector Cell Therapy

Committee on Quality Outcomes of the American Society of Transplant and Cellular Therapy

Research output: Contribution to journalEditorial

1 Scopus citations

Abstract

Immune effector cell (IEC) therapy represents a transformative advancement in oncology, leveraging the immune system to combat various malignancies. This article outlines a comprehensive framework for establishing and maintaining quality standards in IEC therapy amidst rapid scientific and clinical advancements. We emphasize the integration of structured process measures, robust quality assurance, and meticulous outcome evaluation to ensure treatment efficacy and safety. Key components include multidisciplinary expertise, stringent accreditation protocols, and advanced data management systems, which facilitate standardized reporting and continual innovation. The collaborative effort among stakeholders—ranging from patients and healthcare providers to regulatory bodies—is crucial in delivering high-quality IEC therapies. This framework aims to enhance patient outcomes and cement the role of IEC therapy as a cornerstone of modern oncology, promoting continuous improvement and adherence to high standards across the therapeutic spectrum.

Original languageEnglish
Pages (from-to)942-954
Number of pages13
JournalTransplantation and Cellular Therapy
Volume30
Issue number10
DOIs
StatePublished - Oct 2024
Externally publishedYes

Keywords

  • Immune effector cell therapy
  • Patient safety, quality of care
  • Quality improvement
  • Transplant and cellular therapy

Fingerprint

Dive into the research topics of 'In Pursuit of Optimal Outcomes: A Framework for Quality Standards in Immune Effector Cell Therapy'. Together they form a unique fingerprint.

Cite this